Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

Beitrag bei einer Tagung


Details zur Publikation

Autorinnen und Autoren: Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, Heneghan M, Huang J, Harrison S, Minuk G, Joern S, Moreno C, Vierling J, Vincent C, Bowlus C, Lurie Y, Muratori L, Niro G, Hirschfield G, Post A, Zeuzem S, Welzel T, Ch'Ng CL, Levy C, Miller M, Albillos A, Collier JD, Corless L, Dieterich D, Kremer A, Papatheodoridis G, Romeo D, Silveira M, Bernstein D, Cohen-Naftaly M, Floreani A, Borg B, Carey E, Hollywood C, Maliakkal B, Marzioni M, Rabinovitz M, Rupp C, Sheridan D, Stanca C, Swain MG, Veitsman E, Dourakis PS, Wiese P
Verlag: ELSEVIER SCIENCE BV
Verlagsort: AMSTERDAM
Jahr der Veröffentlichung: 2019
Tagungsband: JOURNAL OF HEPATOLOGY
Seitenbereich: E1-E2
ISSN: 0168-8278


FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Kremer, Andreas PD Dr.
Medizinische Klinik 1 - Gastroenterologie, Pneumologie und Endokrinologie


Einrichtungen weiterer Autorinnen und Autoren

Abertawe Bro Morgannwg University Health Board
Casa Sollievo della Sofferenza
Chaim Sheba Medical Center at Tel HaShomer / המרכז הרפואי ע"ש חיים שיבא – תל השומר‎‎
Dayton Gastroenterology, Inc.
General Hospital of Athens Hippocrates / Γενικό Νοσοκομείο Αθηνών «Ιπποκράτειο»
Genkyotex S.A.
Gloucestershire Hospitals
Goethe-Universität Frankfurt am Main
Hôpital Erasme
Hospital Universitario Ramón y Cajal
Hospital Universitario Virgen de la Victoria
Houston Texas Medical Center
Hull and East Yorkshire Hospitals NHS Trust
Icahn School of Medicine at Mount Sinai
Johannes Gutenberg-Universität Mainz
John Buhler Research Center
John Radcliffe Hospital
King's College Hospital (KCH)
Laikο General Hospital of Athens
Mayo Clinic Phoenix
Methodist Le Bonheur Healthcare
New York University (NYU)
NHS Tayside
Northwell Health
Pinnacle Clinical Research
Policlinico Sant'Orsola-Malpighi
Rabin Medical Center / מרכז רפואי רבין‎‎
Rambam Health Care Campus
Southern Therapy and Advanced Research LLC
Tel Aviv Sourasky Medical Center / Ichilov Hospital
Università Politecnica delle Marche (UNIVPM)
Universitätsklinikum Heidelberg
Université de Montréal
University Hospital Ghent
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
University Hospitals Birmingham NHS Foundation Trust
University Hospitals of Cleveland / Case Western Reserve University Hospital
University Hospitals Plymouth NHS Trust
University of Calgary
University of California Davis (UCDAVIS)
University of Miami
University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB
University of Padua
University of Pittsburgh
University of Rochester (UR)
University of Thessaly


Zitierweisen

APA:
Dalekos, G., Invernizzi, P., Nevens, F., Hans, V.V., Zigmond, E., Andrade, R.J.,... Wiese, P. (2019). Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. In JOURNAL OF HEPATOLOGY (pp. E1-E2). Vienna, AUSTRIA: AMSTERDAM: ELSEVIER SCIENCE BV.

MLA:
Dalekos, George, et al. "Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial." Proceedings of the International Liver Congress, Vienna, AUSTRIA AMSTERDAM: ELSEVIER SCIENCE BV, 2019. E1-E2.

BibTeX: 

Zuletzt aktualisiert 2019-14-05 um 09:23